We asked the FDA to treat the approval review process of AMX0035 with urgency. Specifically, we sent a letter to FDA asking the agency to conduct a Priority Review of Amylyx’s New Drug Application (NDA) for AMX0035 and then approve it. The Priority Review is an expedited review process, as opposed to the Standard Review process, which can take upwards of a year after the agency accepts submission of the NDA.
The ALS Ice Bucket Challenge showed us that when small things add up, they can make the impossible happen. As part of our #EveryDropAddsUp campaign, we're asking YOU to share what things add up to make a difference in your life. Below are some of the responses we've received so far.
This program is intended to help defray costs for expenses related to medical equipment, respite, home modifications, communication technology and other items or services related to ALS.
This program is intended to help defray costs for expenses related to medical equipment, respite, home modifications, communication technology and other items or services related to ALS.
This program is intended to help defray costs for expenses related to medical equipment, respite, home modifications, communication technology and other items or services related to ALS.
This program is intended to help defray costs for expenses related to medical equipment, respite, home modifications, communication technology and other items or services related to ALS.
Dr. Heidi Tarr Henson, a Massachusetts woman recently diagnosed with ALS, reflects on on in-the-moment advocacy, teachable moments and the power of setting boundaries with ourselves and others.